|Last Price||Today's Change||52-Week Range||Trading Volume|
|60.29||-0.84 (-1.37%)||45.45 - 71.60||4.9 million (Below Avg)|
Market data as of 4:01PM 11/25/15. Quotes are delayed by at least 15 min.
AbbVie Announces New Data on VIEKIRA PAK® (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis
11/14/2015 9:01 AM ET
AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
11/13/2015 8:00 AM ET